A0081006: 12-month open-label study to evaluate the safety and tolerability of pregabalin as adjunctive therapy in pediatric subjects 1 month to 16 years of age with partial onset seizures and pediatric and adult subjects 5 to 65 years of age with primary

Grants and Contracts Details

Effective start/end date1/20/1512/30/17


  • Parexel International Co: $12,434.00